CMV

COMMUNIQUÉS West-GlobeNewswire

The Real Jerry Maguire Meets Prof. Mike Chan of European Wellness Biomedical Group to Discuss Sports Injuries and Concussion Recovery
30/06/2025
The man who inspired the multiple award-winning movie “Jerry Maguire” meets the pioneering stem cell scientist who is transforming regenerative medicine. Together, they may just hold the key to healing the silent [...]
More Tests, No Insurance Needed: HNL Lab Medicine Grows Self-Pay Offerings
30/06/2025
ALLENTOWN, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine is redefining convenience in healthcare with the expansion of its HNL Lab Tests Direct menu, adding dozens of new self-pay tests that empower patients [...]
AdipoPharma Recognized at American Diabetes Association 85th Annual Meeting for PATAS, Its First-in-Class Whole-Body Insulin-Sensitizing Compound
30/06/2025
CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- AdipoPharma , a biotech company headquartered in France with offices in the U.S. and Belgium, was recognized at the American Diabetes Association’s 85 th Annual Meeting this [...]
NADP Reports Dental Benefits Market on Road to Recovery
30/06/2025
Market Continues to Rebound from Pandemic Era DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- The health of the dental benefits industry showed visible signs of recovery at year-end 2023, following market disruptions [...]
Baylor Genetics’ Chairman and CEO Kengo Takishima Named One of Houston Business Journal’s 2025 Most Admired CEOs
30/06/2025
Award is one of Houston’s most inspiring celebrations of leadership, where CEOs and visionaries are at the helm of the city’s most successful and impactful organizations HOUSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Baylor [...]
Transactions under Novonesis’ share buyback program
30/06/2025
Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated 1,729,099 [...]
IBA – Transparency Notification - Denominator
30/06/2025
June 30 th , 2025 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various [...]
IBA – Notification de Transparence - Dénominateur
30/06/2025
30 juin 2025 Publication effectuée en vertu de l’article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché [...]
OSE Immunotherapeutics Publishes Letter to Shareholders
30/06/2025
OSE Immunotherapeutics Publishes Letter to Shareholders NANTES, France, June 30, 2025, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the publication of its inaugural Letter to [...]
OSE Immunotherapeutics publie une Lettre aux Actionnaires
30/06/2025
OSE Immunotherapeutics publie une Lettre aux Actionnaires NANTES, France, 30 juin 2025, 18 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce la publication de sa première Lettre aux [...]
EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan
30/06/2025
Press Release Paris – June 30, 2025 – EUROAPI today announced the signing of a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, the subsidiary operating its Haverhill manufacturing site, with a [...]
EUROAPI cède le site de Haverhill à Particle Dynamics dans le cadre du plan de transformation FOCUS-27
30/06/2025
Communiqué de presse Paris – Le 30 juin 2025 - EUROAPI annonce ce jour la signature d’un accord (Share Purchase Agreement - SPA) portant sur la cession de 100% des titres de EUROAPI UK Ltd, la filiale exploitant son [...]
Erdem Hospital Launches New Pre-Surgery Education Program for Bariatric Patients
30/06/2025
Photo: Erdem Hospital via FL Communications ISTANBUL, June 30, 2025 (GLOBE NEWSWIRE) -- Erdem Hospital in Istanbul has announced the launch of a new pre-operative education program tailored specifically for bariatric [...]
Portal Biotech Raises $35 Million Series A, Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer
30/06/2025
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development and diagnostics LONDON, June 30, 2025 (GLOBE NEWSWIRE) -- Portal Biotech, a [...]
Mineralys Therapeutics Announces Journal of the American Medical Association (JAMA) Publication of Pivotal Phase 3 Launch-HTN Trial for Lorundrostat
30/06/2025
– The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily demonstrated clinically [...]
Total number of shares and voting rights in Zealand Pharma as of June 30, 2025
30/06/2025
Company announcement – No. 16 / 2025 Total number of shares and voting rights in Zealand Pharma as of June 30, 2025 Copenhagen, Denmark, June 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Acentra Health Earns Fourth Consecutive Recognition on the Washington Business Journal’s Annual ‘Largest Private Companies’ List
30/06/2025
Strategic investments in its solutions and workforce fuel the company’s consistent growth in WBJ’s rankings, earning the No. 43 spot in 2025 MCLEAN, Va., June 30, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology [...]
Aclaris Therapeutics Added to the Russell 2000® and Russell 3000® Indexes
30/06/2025
WAYNE, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Completion of Share Buy-back Program
30/06/2025
Company Announcement COPENHAGEN, Denmark; June 30, 2025 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on June 26, 2025. On March 25, 2025, Genmab announced the initiation of a [...]

Pages